Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Department of Neuromuscular Diseases, National Neurological Institute C. Besta, Milan, Italy.
F
F
Baggi
F
F
Andreetta
C
C
Antozzi
O
O
Simoncini
P
P
Confalonieri
S
S
Labeit
F
F
Cornelio
R
R
Mantegazza
D001323:Autoantibodies / Q000097:blood*; D064211:Connectin; D005260:Female; D006801:Humans; D006965:Hyperplasia; D008297:Male; D008565:Membrane Proteins / Q000276:immunology; D009124:Muscle Proteins / Q000276:immunology*; D009157:Myasthenia Gravis / Q000097:blood / Q000150:complications / Q000276:immunology*; D011494:Protein Kinases / Q000276:immunology*; D019837:Ryanodine Receptor Calcium Release Channel / Q000276:immunology*; D013934:Thymectomy; D013945:Thymoma / Q000097:blood / Q000150:complications / Q000276:immunology* / Q000601:surgery; D013950:Thymus Gland / Q000473:pathology; D013953:Thymus Neoplasms / Q000097:blood / Q000150:complications / Q000276:immunology* / Q000601:surgery
D001323:Autoantibodies; D064211:Connectin; D008565:Membrane Proteins; D009124:Muscle Proteins; D019837:Ryanodine Receptor Calcium Release Channel; C577285:TTN protein, human; D011494:Protein Kinases